Cargando…

Distinct transcription factor networks control neutrophil-driven inflammation

Neutrophils display distinct gene expression patters depending on their developmental stage, activation state and tissue microenvironment. To determine the transcription factor networks that shape these responses in a mouse model, we integrated transcriptional and chromatin analyses of neutrophils d...

Descripción completa

Detalles Bibliográficos
Autores principales: Khoyratty, Tariq E, Ai, Zhichao, Ballesteros, Ivan, Eames, Hayley L, Mathie, Sara, Martín-Salamanca, Sandra, Wang, Lihui, Hemmings, Ashleigh, Willemsen, Nicola, von Werz, Valentin, Zehrer, Annette, Walzog, Barbara, van Grinsven, Erinke, Hidalgo, Andres, Udalova, Irina A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7611586/
https://www.ncbi.nlm.nih.gov/pubmed/34282331
http://dx.doi.org/10.1038/s41590-021-00968-4
Descripción
Sumario:Neutrophils display distinct gene expression patters depending on their developmental stage, activation state and tissue microenvironment. To determine the transcription factor networks that shape these responses in a mouse model, we integrated transcriptional and chromatin analyses of neutrophils during acute inflammation. We show active chromatin remodelling at two transition stages: bone marrow-to-blood and blood-to-tissue. Analysis of differentially accessible regions revealed distinct sets of putative transcription factors associated with control of neutrophil inflammatory responses. Using ex vivo and in vivo approaches, we confirmed that RUNX1 and KLF6 modulate neutrophil maturation, whereas RELB, IRF5 and JUNB drive neutrophil effector responses, and RFX2 and RELB promote survival. Interfering with neutrophil activation by targeting one of these factors, JUNB, reduced pathological inflammation in a mouse model of myocardial infarction. Our study therefore represents a blueprint for transcriptional control of neutrophil responses in acute inflammation and opens possibilities for stage-specific therapeutic modulation of neutrophil function in disease.